After 2 years, CVS has decided that clinical trial support was no longer a part of its business mission. That leaves Walgreen's and Walmart as pharmacy providers still in the game. Nothing specific in the announcement provides what problems may have been encountered that led to the decision. These problems may have already been solved by the remaining players, but if not, they would be valuable lessons for those still in the game. With the continued need for patient support outside of physician offices and clinics, I am wondering how the industry will respond to keep decentralized trials available to the most patients, especially those in under served urban and rural areas.
Information and interesting ideas
Topics posted here will be in the realm of bioanalysis and biomarkers as part of new therapeutic development, with the occasional post of scientific topics that I find interesting.
Thursday, May 18, 2023
CVS Steps out of clinical trial support
Subscribe to:
Post Comments (Atom)
FDA and CMS issue statement on LDTs: Americans Deserve Accurate and Reliable Diagnostic Tests, Wherever They Are Made
This joint statement notes the evolution of Laboratory Developed Tests (LDTs) from the initial rule and approach the FDA had for oversite, a...
-
FDA has released an app - " Drugs@FDA includes most of the drug products approved since 1939. The majority of patient information, l...
-
Post-BREXIT, the UKs MHRA joined ICH as an independent body in May 2022. This notification on the Agency's Blog provides an overview o...
-
If you have or haven't looked at the ICH E6 revision 3 GCP guideline, this may be of interest to see how others perceive the difference...
No comments:
Post a Comment